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Abstract Mutations in the human immunodeficiency virus type
1 (HIV-1) vpr gene only slightly reduce the replication rate of the
virus. To study the role of HIV-1 Vpr in biological effects on
cells, HEp-2 cells, which express HIV-1 Vpr constitutively but at
a low level, were established. While control HEp-2 cells
underwent apoptosis when incubated with sorbitol, the morpho-
logical and biochemical apoptotic changes were inefficiently
induced in the HIV-1 Vpr-expressing cells by the same
treatment. These results clearly indicate that HIV-1 Vpr has
anti-apoptotic activity, and raise the possibility that Vpr acts as a
weak activator of virus replication through anti-apoptosis.
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1. Introduction
Human immunode¢ciency virus type 1 (HIV-1) carries a
number of unique genes in its genome not found in simple
retroviruses [1^4]. These are two regulatory [2] and four ac-
cessory genes [3,4]. Of the four accessory proteins, Vif, Vpu,
and Nef enhance viral infectivity at least in certain cell types
[3,4], and have thus clear functional roles for viral replication.
However, it is uncertain whether Vpr much a¡ects the virus
replication in various types of cells [5^9]. In contrast to its role
in viral replication, Vpr has now been recognized as a key to
crucial interactions between HIV-1 and host cells [3,4]. HIV-1
Vpr arrests cells in the G2 phase of the cell cycle [10^13],
induces cell di¡erentiation [14], and is responsible for the reg-
ulation of apoptosis [15^18]. Contrasting results have been
reported for the e¡ect of HIV-1 Vpr on apoptosis and anti-
apoptosis [15^18].
In this report, to investigate interactions between HIV-1
Vpr and cells, HIV-1 vpr was introduced into HEp-2 cells to
obtain cells constitutively expressing Vpr. The HEp-2 cell sys-
tem has been shown to be very sensitive for detection of
apoptosis [19,20]. We analyzed here the ability of HIV-1
Vpr to regulate apoptosis by this HEp-2/Vpr system.
2. Materials and methods
2.1. Cells and transfection
A human epidermoid carcinoma cell line HEp-2 (ATCC CCL23)
and an SV40-transformed African green monkey kidney cell line COS-
7 (ATCC CRL1651) were maintained in Eagle’s minimal essential
medium supplemented with 10% fetal calf serum. For transfection,
uncleaved plasmid DNA was introduced into cells by the calcium-
phosphate coprecipitation method [21].
2.2. DNA constructs
The expression plasmid pME18Neo-Fvpr carrying the Flag and
HIV-1 vpr sequences has been previously described [22]. A control
plasmid pME18Neo lacking the HIV-1 vpr sequence was constructed
by removing the XhoI-NotI fragment from pME18Neo-Fvpr.
2.3. Western blotting
Western immunoblotting was performed as previously described
[23]. Vpr was detected by the ECL system (Amersham) using anti-
Flag monoclonal antibody M2 (International Biotechnologies).
2.4. RT-PCR
For reverse transcription-polymerase chain reaction (RT-PCR), to-
tal RNA was extracted from cells with Isogen (Nippon Gene), and
complementary DNA (cDNA) was synthesized from 1 Wg of the RNA
with the First-Strand cDNA Synthesis Kit (Pharmacia Biotech). PCR
was carried out using the TaKaRa Taq system (Takara Shuzo) essen-
tially as previously described [17]. The primers for HIV-1 vpr (Vpr-1
and Vpr-2) and for glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) are shown in Table 1.
2.5. Assays for apoptosis
Apoptosis was induced in HEp-2 cells by treatment with sorbitol as
previously described [19]. Apoptosis was monitored morphologically
by cell shrinkage and biochemically by fragmentation of chromosomal
DNA into nucleosomal oligomers as previously described [19,20].
3. Results
3.1. Establishment of HEp-2 cells expressing HIV-1 Vpr
To study the biological e¡ects of HIV-1 Vpr on cells, par-
ticularly the ability of Vpr to regulate apoptosis, a Vpr ex-
pression vector designated pME18Neo-Fvpr was transfected
into HEp-2 cells and COS-7 cells, which are very sensitive to
transfection analysis. A plasmid designated pME18Neo served
as negative control. Fig. 1A,B shows the transient expression
of HIV-1 Vpr as monitored by Western blot analysis of HEp-
2 and COS-7 cells transfected with the vectors. HIV-1 Vpr
was readily detected in HEp-2 cells as well as in COS-7 cells.
After con¢rmation of the transient expression of Vpr in HEp-
2 cells, transfected cells were cultured in the presence of 300
Wg of G418 per ml, and surviving cells were collected after
2 weeks. Cells were pooled to avoid clonal selection of cells
with an extreme phenotype. Following G418 selection, lysates
were prepared from HEp-R (transfected with pME18Neo-
Fvpr) and HEp-C (transfected with pME18Neo) cells, and
subjected to Western blot analysis. As shown in Fig. 1C, no
speci¢c Vpr expression was detected in HEp-R cells. The ex-
periments were repeated with the same negative results.
A low level of HIV-1 Vpr expression in HEp-R cells might
account for the results described above. We therefore moni-
tored the expression of Vpr-RNA by RT-PCR using the pri-
mer pairs indicated in Table 1. As shown in Fig. 2, the RNA
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of HIV-1 Vpr was easily detected in HEp-R but not in HEp-C
cells. The negative results obtained without RT in this assay
substantiated the expression of Vpr RNA in HEp-R cells.
In total, we concluded that a low level of HIV-1 Vpr is
expressed in the HEp-R cells.
3.2. Anti-apoptotic nature of HEp-R cells
We examined the apoptotic responses of HEp-R and HEp-
C cells to sorbitol treatment. We previously demonstrated that
parental HEp-2 cells e⁄ciently and rapidly undergo apoptosis
when treated with sorbitol [19]. HEp-2 cells, therefore, can be
used for detection of anti-apoptotic activity of viruses [19].
The apoptosis was monitored morphologically and biochemi-
cally as previously described for HEp-2 and HeLa cells
[19,20,24]. As shown in Fig. 3, morphological changes of
HEp-C cells such as rounding and shrinkage were easily ob-
served shortly after sorbitol treatment as previously described
for HEp-2 cells. In contrast, HEp-R cells were quite resistant
to the sorbitol treatment, and a relatively minor portion of
cells displayed morphological changes. These experiments
were repeated with essentially the same results. To determine
whether biochemical apoptotic changes were induced in cells,
the degree of DNA fragmentation was quantitatively deter-
mined. As shown in Fig. 4A, HEp-C and HEp-R cells were
clearly di¡erent with respect to the induction of nucleosomal
DNA ladder by sorbitol. HEp-R cells were more resistant
than HEp-C cells to the sorbitol treatment. In good agreement
with this observation, after sorbitol treatment, a smaller pro-
portion of fragmented DNA was found in HEp-R cells than
in HEp-C cells (Fig. 4B).
4. Discussion
In this report, we have demonstrated that HEp-2 cells ex-
pressing the HIV-1 Vpr protein (HEp-R) are relatively resist-
ant to the induction of apoptosis by sorbitol. This observation
supports the notion of Conti et al. that HIV-1 Vpr is a neg-
ative regulator of apoptosis [17]. They have demonstrated that
a low level of Vpr expression detectable by Western blotting is
su⁄cient to render cells resistant to apoptosis [17]. We showed
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Table 1
Primers used for RT-PCR in this study
Gene GenBank no. Sequence of primers Products (bp)
Vpr-1
Sense M19921 5P-GCCATACAATGAATGGACACTAG-3P (5597^5619) 244
Antisense 5P-ACTGGCTCCATTTCTTGCTCTC-3P (5819^5840)
Vpr-2
Sense M19921 5P-GAAGACCAAGGGCCACAGAG-3P (5574^5593) 264
Antisense 5P-GGCTCCATTTCTTGCTCTCCT-3P (5817^5837)
GAPDH
Sense M33197 5P-ACGCATTTGGTCGTATTGGG-3P (86^105) 231
Antisense 5P-TGATTTTGGAGGGATCTCGC-3P (297^316)
Fig. 1. Expression of vpr as monitored by Western blotting. HEp-2
(A) and COS-7 (B) cells were transfected with pME18Neo-Fvpr or
pME18Neo, and 2 days later lysates were prepared for Western blot
analysis as previously described [23]. Cell lysates prepared from
HEp-R (stably transfected with pME18Neo-Fvpr) and HEp-C (sta-
bly transfected with pME18Neo) cells selected by G418 were also
analyzed (C). Lanes in A and B: 1, Vpr expression vector pME18-
Neo-Fvpr; 2, negative control pME18Neo. Lanes in C: 1, COS-7
cells transiently transfected with pME18Neo-Fvpr; 2, HEp-R cells;
3, HEp-C cells. Arrows indicate the position of the Flag-Vpr pro-
tein.
Fig. 2. Expression of vpr as monitored by RT-PCR. Total RNA
was extracted from HEp-C and HEp-R cells and subjected to RT-
PCR analysis using primer pairs listed in Table 1. Ampli¢ed prod-
ucts were run through a 3% agarose gel and visualized by ethidium
bromide staining. Lanes in A: a, HEp-R RNA (Vpr-1); b, HEp-C
RNA (Vpr-1); c, HEp-R RNA (Vpr-2); d, HEp-C RNA (Vpr-2);
e; HEp-R RNA without RT (Vpr-1); f, HEp-R RNA without RT
(Vpr-2). The arrowhead and arrow indicate the positions of 264 and
244 bp DNAs, respectively. Lanes in B: a, HEp-R RNA (internal
control GAPDH); b, HEp-C RNA (internal control GAPDH). The
arrow indicates the position of 231 bp DNA.
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here that a faint amount of Vpr, non-detectable by Western
blotting, is enough for anti-apoptotic action. Since clonal se-
lection of cells other than G418 resistance was not carried
out in our study described here, the anti-apoptotic nature of
HEp-R cells should be a general property of Vpr-expressing
cells.
Our ¢ndings described here have important biological im-
plications. The virion protein Vpr can interfere with the phys-
iological turnover of cells at an early phase of infection, and
thus can facilitate virus persistence among cells. This anti-
apoptotic e¡ect of Vpr may also result in the slight enhance-
ment of virus replication in cells as previously reported for
HSV-1 [19], and subsequently, virus spread in an individual.
Reports by us and others are consistent with this hypothesis
[5,25].
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Fig. 3. Morphological apoptotic changes of HEp-2 cells. HEp-C
(A^F) and HEp-R (G^L) cells were cultured for 1 h in the absence
(A^C and G^I) or presence of sorbitol (0.3 M) (D^F and J^L), and
then cultured in sorbitol-free medium for 1 h as previously de-
scribed [19]. Photographs of various microscope ¢elds were taken.
Fig. 4. Biochemical apoptotic changes of HEp-2 cells.
[3H]Thymidine-labeled HEp-C (lanes 1, 3, and 5 in A) and HEp-R
(lanes 2, 4, and 6 in A) cells were incubated in medium containing
sorbitol (lanes 1 and 2, without sorbitol; lanes 3 and 4, 0.3 M sor-
bitol; lanes 5 and 6, 0.5 M sorbitol) for 1 h, and then incubated in
medium without sorbitol for an additional 1 h as previously de-
scribed [19]. Fragmented DNA was extracted, and analyzed in a
1.5% agarose gel (A) as previously described [19,20]. For quantita-
tion, radioactivities in fractions of total and fragmented DNA were
determined and the ratio was calculated (B) as previously described
[19,20]. Symbols in B: open circles, HEp-C cells; closed circles,
HEp-R cells.
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